AstraZeneca: AI in Drug Discovery & Development - Digital Innovation and Transformation

Currently, it takes a staggering 10-15 years and costs $2.6 billion to develop a new drug, and an astonishing proportion of this is lost in the 90% of candidates that fail. AstraZeneca (AZ) is one of the world's largest Pharmaceutical companies and is incorporating AI in every step of the R&D chain from drug discovery to launch to make this process safer, quicker and less costly. The first step is learning more about diseases. AZ is using knowledge graphs (networks of vast scientific data and the relationship between these) to gather new insights about diseases which would allow for more focused research. In order to learn more about pathology, we must gain a firm understanding of human genomes.